Cite
HARVARD Citation
Alikhanyan, K. et al. (2020). Targeting alveolar macrophages shows better treatment response than deletion of interstitial macrophages in EGFR mutant lung adenocarcinoma. Immunity, inflammation and disease. 8 (2), pp. 181-187. [Online].